The landscape of blood sugar treatment is advancing with the emergence of GLP-1 patches . These innovative devices offer a likely simpler alternative to needle administrations for individuals managing diabetes mellitus type 2 . Such a system deliver glucagon-like peptide-1 directly through the ep